推荐产品
生物源
mouse
品質等級
抗體表格
purified antibody
抗體產品種類
primary antibodies
無性繁殖
FP5A, monoclonal
物種活性
human
製造商/商標名
Chemicon®
技術
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
western blot: suitable
同型
IgG1κ
NCBI登錄號
UniProt登錄號
運輸包裝
wet ice
目標翻譯後修改
unmodified
基因資訊
human ... SLC5A5(6528)
特異性
钠/碘同向转运体(NIS)。该表位被认为位于人类NIS的625-643氨基酸区域。该抗体可能对麦芽糖结合蛋白有一定反应性。
免疫原
与人NIS(C端)氨基酸468-643相对应的麦芽糖结合蛋白融合蛋白。
表位:氨基酸625-643
應用
使用该抗钠/碘同向转运体检测钠/碘同向转运体,a.a.625-643,克隆经验证的FP5A,以应用于IH、IH(P) & WB。
免疫印迹。该抗体可识别分子量约为97 kDa的主带以及15 kDa、30 kDa、68 kDa和160 kDa的小带。
免疫组化。该抗体对石蜡包埋组织切片有效,这些切片使用10mM柠檬酸盐缓冲蒸汽提取抗原30分钟。
最佳工作稀释度必须由最终用户进行确定。
免疫组化。该抗体对石蜡包埋组织切片有效,这些切片使用10mM柠檬酸盐缓冲蒸汽提取抗原30分钟。
最佳工作稀释度必须由最终用户进行确定。
外觀
形式:纯化
其他說明
浓度:请参考批次特异性浓缩物的检验报告。
法律資訊
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Not finding the right product?
Try our 产品选型工具.
儲存類別代碼
10 - Combustible liquids
水污染物質分類(WGK)
WGK 2
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Journal for immunotherapy of cancer, 11(4) (2023-04-06)
Gastric cancer (GC) that metastasizes to the peritoneum is fatal. CF33 and its genetically modified derivatives show cancer selectivity and oncolytic potency against various solid tumors. CF33-hNIS and CF33-hNIS-antiPDL1 have entered phase I trials for intratumoral and intravenous treatments of
Clinical cancer research : an official journal of the American Association for Cancer Research, 25(19), 5997-6008 (2019-06-15)
The innate tumor homing potential of mesenchymal stem cells (MSCs) has been used for a targeted delivery of the theranostic sodium iodide symporter (NIS) transgene into solid tumors. We have previously shown that external beam radiotherapy (EBRT) results in the
Molecular therapy oncolytics, 30, 238-253 (2023-09-13)
New treatment strategies are urgently needed for glioblastoma (GBM)-a tumor resistant to standard-of-care treatment with a high risk of recurrence and extremely poor prognosis. Based on their intrinsic tumor tropism, adoptively applied mesenchymal stem cells (MSCs) can be harnessed to
Molecular therapy oncolytics, 27, 272-287 (2022-12-03)
Sodium iodide symporter (NIS) gene transfer for active accumulation of iodide in tumor cells is a powerful theranostic strategy facilitating both diagnostic and therapeutic application of radioiodide. In glioblastoma (GBM), the blood-brain barrier (BBB) presents an additional delivery barrier for
JAMA otolaryngology-- head & neck surgery, 141(8), 739-744 (2015-06-05)
Sodium iodide symporter (NIS) expression in adenoid cystic carcinoma (ACC) has not been fully elucidated in the literature, and it is unclear whether radioactive iodine may be a potential therapeutic modality. To our knowledge, the present study includes the largest
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门